US 11793810
Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
granted A61KA61K31/437A61K31/444
Quick answer
US patent 11793810 (Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/437, A61K31/444, A61K31/513, A61K31/567